SCHEMBL22457743

SCHEMBL22457743

CN(C(=O)OC(C)(C)C)[C@@H](Cc1ccccc1)C(=O)N(C)[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITGB3 P05106 1/20 0.45
▸ ITGA2B P08514 1/20 0.45
▸ REN P00797 1/20 0.44
▸ MMP13 P45452 1/20 0.43
▸ MMP2 P08253 1/20 0.43
▸ MMP9 P14780 1/20 0.43
▸ ATM Q13315 1/20 0.41
▸ ITGA4 P13612 1/20 0.40
▸ ITGB7 P26010 1/20 0.40
▸ ACE P12821 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ CTSS P25774 2/20 0.39
▸ ADAMTS5 Q9UNA0 1/20 0.39
▸ CTSL P07711 1/20 0.39
▸ CTSB P07858 1/20 0.39
▸ CTSK P43235 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ SLC7A5 Q01650 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30688551 1.00 ITGB3 (0.45) ITGB3ITGA2BRENMMP13MMP2
SCHEMBL30688558 1.00 ITGB3 (0.45) ITGB3ITGA2BRENMMP13MMP2
SCHEMBL1401042 0.95 MMP13 (0.46) ITGB3ITGA2BRENMMP13MMP2
SCHEMBL65502 0.95 MMP13 (0.46) ITGB3ITGA2BRENMMP13MMP2
SCHEMBL2476924 0.95 MMP13 (0.46) ITGB3ITGA2BRENMMP13MMP2
SCHEMBL6326103 0.89 REN (0.45) RENMMP13MMP9ATMITGA4
SCHEMBL24435948 0.88 NPY5R (0.45) RENMMP13ATMITGA4ITGB7
SCHEMBL3268338 0.87 REN (0.44) ITGB3ITGA2BRENMMP13ATM
SCHEMBL1401223 0.87 ALDH1A1 (0.48) ITGB3ITGA2BRENMMP13ACE
SCHEMBL18248052 0.87 ALDH1A1 (0.48) ITGB3ITGA2BRENMMP13ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12240871-B2 Method for producing peptide compound NISSAN CHEMICAL CORPORATION (JP) 2025-03-04 — — US disclosed
CN-111164092-B Process for producing peptide compound 日产化学株式会社 2023-12-26 — — CN disclosed
US-20220153777-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND NISSAN CHEMICAL CORPORATION (JP) 2022-05-19 — — US disclosed
US-20220153777-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND NISSAN CHEMICAL CORPORATION (JP) 2022-05-19 — — US disclosed
WO-2020189621-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND 日産化学株式会社 2020-09-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12240871-B2 Method for producing peptide compound NGLY1, NPPA, NPEPPS ITGB3 3772/4885ITGA2B 4363/4885REN 1579/4885
US-20220153777-A1 METHOD FOR PRODUCING PEPTIDE COMPOUND NGLY1, NPPA, NPEPPS ITGB3 3772/4885ITGA2B 4363/4885REN 1579/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback